Abstract
Objective To conduct a systematic review of cost-effectiveness, cost-utility, and cost-benefit studies of DPP-4 inhibitors for diabetes treatment versus other antidiabetics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have